L&K Biomed Ltd. (KOSDAQ:156100)
South Korea · Delayed Price · Currency is KRW 7,700.00
-300.00 (-3.75%)
At close: Jul 18, 2025, 3:30 PM KST
L&K Biomed Revenue
L&K Biomed had revenue of 8.89B KRW in the quarter ending March 31, 2025, a decrease of -2.55%. This brings the company's revenue in the last twelve months to 35.86B, up 14.58% year-over-year. In the year 2024, L&K Biomed had annual revenue of 36.09B with 20.69% growth.
Revenue (ttm)
35.86B
Revenue Growth
+14.58%
P/S Ratio
4.28
Revenue / Employee
394.06M
Employees
60
Market Cap
153.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.09B | 6.19B | 20.69% |
| Dec 31, 2023 | 29.90B | 10.14B | 51.28% |
| Dec 31, 2022 | 19.77B | 4.39B | 28.59% |
| Dec 31, 2021 | 15.37B | -3.98B | -20.58% |
| Dec 31, 2020 | 19.36B | -7.22B | -27.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |